|
|
||||||||
Original Research Communication |
1 From the Centre for In Vivo Body Composition and Gastrointestinal Investigation Unit, The University of Sydney at Royal North Shore Hospital, Sydney, Australia (RDH), and the Cancer Care Centre, St George Hospital, Sydney, Australia (BJA).
Background: Total body potassium (TBK) is known to decline throughout adulthood. The relations between physical activity, age, anabolic hormones, and TBK have rarely been considered.
Objective: We sought to describe the relation between habitual physical activity, age, serum estradiol, and insulin-like growth factor I (IGF-I) and TBK in postmenopausal women.
Design: TBK, fat-free mass (FFM), moderate-to-vigorous-intensity physical activity (MVPA; assessed with use of a semistructured interview), and serum concentrations of estradiol, IGF-I, and IGF binding protein 3 (IGFBP-3) were quantified in 51 healthy white women aged 5476 y.
Results: The potassium content of FFM declined curvilinearly with age, indicating an accelerated loss of skeletal muscle after 65 y of age. With the data split into high (n = 25) and low (n = 26) MVPA groups, the active women had 6.5% more potassium per FFM than did their less-active counterparts (P < 0.01). In multiple regression analysis, MVPA was the major determinant of the potassium content of FFM (P = 0.02), such that an active 70-y-old had the potassium content value of a 55-y-old sedentary woman. Serum estradiol, IGF-I, and IGFBP-3 were not significant determinants of the potassium content of FFM.
Conclusions: These data suggest that 1) habitual physical activity can significantly influence FFM potassium content; 2) physical activity must, therefore, be considered if the effect of aging per se on TBK is to be clarified; and 3) MVPA, such as that pursued by the active women in the present study (eg, walking, dancing, floor exercises, and swimming), can assist in preventing sarcopenia in older women.
Key Words: Total body potassium fat-free mass physical activity aging postmenopausal women estradiol insulin-like growth factor I sarcopenia
This article has been cited by other articles:
![]() |
R. D Hansen Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS Study Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1180 - 1181. [Full Text] [PDF] |
||||
![]() |
S. Baron-Hay, F. Boyle, A. Ferrier, and C. Scott Elevated Serum Insulin-Like Growth Factor Binding Protein-2 as a Prognostic Marker in Patients with Ovarian Cancer Clin. Cancer Res., March 1, 2004; 10(5): 1796 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. He, M. Heo, S. Heshka, J. Wang, R. N Pierson Jr, J. Albu, Z. Wang, S. B Heymsfield, and D. Gallagher Total body potassium differs by sex and race across the adult age span Am. J. Clinical Nutrition, July 1, 2003; 78(1): 72 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Figueroa, S. B. Going, L. A. Milliken, R. M. Blew, S. Sharp, P. J. Teixeira, and T. G. Lohman Effects of Exercise Training and Hormone Replacement Therapy on Lean and Fat Mass in Postmenopausal Women J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2003; 58(3): M266 - 270. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |